Trial Outcomes & Findings for The Influence of a Medication Adherence Smartphone Application on Medication Adherence in Chronic Illness (NCT NCT05098743)

NCT ID: NCT05098743

Last Updated: 2024-08-19

Results Overview

The ARMS is a global (continuous) 12-item scale, responses range from 1 (none) to 4 (all of the time) with a possible score of 12-48, patients with low ARMS scores indicate better adherence, it is valid and reliable in a low-literacy chronic disease population.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

65 participants

Primary outcome timeframe

Baseline to 30 days.

Results posted on

2024-08-19

Participant Flow

Participants were recruited from a healthcare center, as noted in the protocol section.

Participant milestones

Participant milestones
Measure
Participants Using the Medication Adherence Mobile Application.
Participants in this arm will use the Medisafe app to receive medication reminders for thirty days. Medisafe smartphone mobile application: The medication adherence smartphone mobile application (app) will provide reminders to take individual patient medications and offers medication information and a social support feature.
Participants Using a Printed Copy of Their Medication List.
Participants in this arm will use a printed out copy of their medication list for thirty days. Printed medication list: Patients will receive a printed out medication list from their electronic medical record.
Overall Study
STARTED
32
33
Overall Study
COMPLETED
30
31
Overall Study
NOT COMPLETED
2
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Participants Using the Medication Adherence Mobile Application.
Participants in this arm will use the Medisafe app to receive medication reminders for thirty days. Medisafe smartphone mobile application: The medication adherence smartphone mobile application (app) will provide reminders to take individual patient medications and offers medication information and a social support feature.
Participants Using a Printed Copy of Their Medication List.
Participants in this arm will use a printed out copy of their medication list for thirty days. Printed medication list: Patients will receive a printed out medication list from their electronic medical record.
Overall Study
One participant had no data because they were unable to download the app despite multiple attempts
1
0
Overall Study
Lost to Follow-up
1
2

Baseline Characteristics

The Influence of a Medication Adherence Smartphone Application on Medication Adherence in Chronic Illness

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Participants Using the Medication Adherence Mobile Application.
n=30 Participants
Participants in this arm will use the Medisafe app to receive medication reminders for thirty days. Medisafe smartphone mobile application: The medication adherence smartphone mobile application (app) will provide reminders to take individual patient medications and offers medication information and a social support feature.
Participants Using a Printed Copy of Their Medication List.
n=31 Participants
Participants in this arm will use a printed out copy of their medication list for thirty days. Printed medication list: Patients will receive a printed out medication list from their electronic medical record.
Total
n=61 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
27 Participants
n=5 Participants
25 Participants
n=7 Participants
52 Participants
n=5 Participants
Age, Categorical
>=65 years
3 Participants
n=5 Participants
6 Participants
n=7 Participants
9 Participants
n=5 Participants
Age, Continuous
53.50 years
n=5 Participants
51 years
n=7 Participants
53 years
n=5 Participants
Sex: Female, Male
Female
17 Participants
n=5 Participants
12 Participants
n=7 Participants
29 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
19 Participants
n=7 Participants
32 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
5 participants
n=5 Participants
2 participants
n=7 Participants
7 participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
10 participants
n=5 Participants
13 participants
n=7 Participants
23 participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic/Latino
4 participants
n=5 Participants
10 participants
n=7 Participants
14 participants
n=5 Participants
Race/Ethnicity, Customized
Native American or Alaska Native
1 participants
n=5 Participants
0 participants
n=7 Participants
1 participants
n=5 Participants
Race/Ethnicity, Customized
White
6 participants
n=5 Participants
3 participants
n=7 Participants
9 participants
n=5 Participants
Race/Ethnicity, Customized
Other
3 participants
n=5 Participants
2 participants
n=7 Participants
5 participants
n=5 Participants
Race/Ethnicity, Customized
Chose not to respond
1 participants
n=5 Participants
1 participants
n=7 Participants
2 participants
n=5 Participants
Region of Enrollment
United States
30 Participants
n=5 Participants
31 Participants
n=7 Participants
61 Participants
n=5 Participants
ARMS
18.5 units on a scale
n=5 Participants
17.0 units on a scale
n=7 Participants
18.0 units on a scale
n=5 Participants
SEAMS
29.0 units on a scale
n=5 Participants
31.0 units on a scale
n=7 Participants
29.0 units on a scale
n=5 Participants

PRIMARY outcome

Timeframe: Baseline to 30 days.

The ARMS is a global (continuous) 12-item scale, responses range from 1 (none) to 4 (all of the time) with a possible score of 12-48, patients with low ARMS scores indicate better adherence, it is valid and reliable in a low-literacy chronic disease population.

Outcome measures

Outcome measures
Measure
Participants Using the Medication Adherence Mobile Application.
n=30 Participants
Participants in this arm will use the Medisafe app to receive medication reminders for thirty days. Medisafe smartphone mobile application: The medication adherence smartphone mobile application (app) will provide reminders to take individual patient medications and offers medication information and a social support feature.
Participants Using a Printed Copy of Their Medication List.
n=31 Participants
Participants in this arm will use a printed out copy of their medication list for thirty days. Printed medication list: Patients will receive a printed out medication list from their electronic medical record.
Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS)
-4.0 score on a scale
Interval -8.0 to -1.0
-1.0 score on a scale
Interval -3.0 to 0.0

PRIMARY outcome

Timeframe: Baseline to 30 days.

The SEAMS is a global (continuous) 13-item scale, responses range from 1 (not confident) to 3 (very confident), with a possible score of 13-39. Patients with higher scores indicate higher levels of self-efficacy for medication adherence. It is valid and reliable in low-literacy chronic disease populations. Patients are asked their level of confidence about taking medications correctly.

Outcome measures

Outcome measures
Measure
Participants Using the Medication Adherence Mobile Application.
n=30 Participants
Participants in this arm will use the Medisafe app to receive medication reminders for thirty days. Medisafe smartphone mobile application: The medication adherence smartphone mobile application (app) will provide reminders to take individual patient medications and offers medication information and a social support feature.
Participants Using a Printed Copy of Their Medication List.
n=31 Participants
Participants in this arm will use a printed out copy of their medication list for thirty days. Printed medication list: Patients will receive a printed out medication list from their electronic medical record.
Change in Medication Self-efficacy as Measured by the Self-efficacy for Appropriate Medication Use Scale (SEAMS)
3.5 score on a scale
Interval 0.0 to 8.0
0.0 score on a scale
Interval -3.0 to 3.0

Adverse Events

Participants Using the Medication Adherence Mobile Application.

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Participants Using a Printed Copy of Their Medication List.

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Christa Hartch, PI

Vanderbilt University

Phone: 203-979-2044

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place